Home LiteratureArticle Details
PMID: 9616224 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Differential expression of the insulin gene transcriptional repressor CCAAT/enhancer-binding protein beta and transactivator islet duodenum homeobox-1 in rat pancreatic beta cells during the development of diabetes mellitus.

The Journal of clinical investigation ·Vol. 101 ·No. 11 ·1998-06-01 ·Pages 2528-39

Seufert J, Weir GC, Habener JF

Abstract

Impairment of insulin secretion due to prolonged hyperglycemia is believed to contribute to the manifestation of diabetes mellitus, often referred to as glucose toxicity of pancreatic beta cells. In addition, impaired beta cell function has been associated with elevated islet triglyceride content (lipotoxicity). Impaired functions of the transactivating factors islet duodenum homeobox-1 (IDX-1) and RIPE3b-binding proteins have been implicated in the pathological downregulation of insulin gene transcription by high glucose levels in pancreatic beta cell lines in vitro, and, similarly, the exposure of pancreatic islets to fatty acids decreases IDX-1 expression. Previously, we identified the basic leucine zipper transcription factor CCAAT/enhancer-binding protein beta (C/ EBPbeta) as an inhibitor of insulin gene transcription in pancreatic beta cells and showed that the expression of C/EBPbeta is upregulated in insulinoma-derived beta cell lines by sustained high glucose concentrations. Here we describe the regulation of the expression of IDX-1, C/EBPbeta, and insulin at the mRNA and protein levels in pancreatic islets in animal models of diabetes mellitus. Concomitant with a downregulation of IDX-1 and insulin expression, C/EBPbeta is upregulated in association with the manifestation of hyperglycemia during the development of diabetes in the Zucker diabetic fatty (fa/fa) rat and in the 90% pancreatectomy rat model of diabetes. This regulation is demonstrated to influence both the amount of cellular protein and the level of steady state messenger RNA. Our findings indicate that the differential dysregulation of both IDX-1 and C/EBPbeta, in response to sustained hyperglycemia or hyperlipidemia, may be involved in the impairment of insulin gene expression during the manifestation of diabetes mellitus.

MeSH Terms
Animals CCAAT-Enhancer-Binding Proteins DNA-Binding Proteins/biosynthesis,genetics Diabetes Mellitus/metabolism Homeodomain Proteins/biosynthesis,genetics Insulin/genetics Islets of Langerhans/metabolism Male Nuclear Proteins/biosynthesis,genetics Pancreatectomy RNA, Messenger/analysis Rats Rats, Sprague-Dawley Rats, Wistar Rats, Zucker Trans-Activators/biosynthesis,genetics
Chemicals
CCAAT-Enhancer-Binding Proteins DNA-Binding Proteins Homeodomain Proteins Insulin Nuclear Proteins RNA, Messenger Trans-Activators pancreatic and duodenal homeobox 1 protein
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Seufert J
Laboratory of Molecular Endocrinology, Massachusetts General Hospital, Howard Hughes Medical Institute, Harvard Medical School, Boston, Massachusetts 02114, USA.
Weir G C
Habener J F
References (66)
66 references, click to expand
  1. Reduction of insulin gene transcription in HIT-T15 beta cells chronically exposed to a supraphysiologic glucose concentration is associated with loss of STF-1 transcription factor expression.
    Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9127-31 PMID: 7568086
  2. The C/EBP family of transcription factors.
    Immunobiology. 1995 Jul;193(2-4):171-85 PMID: 8530141
  3. Leptin receptor missense mutation in the fatty Zucker rat.
    Nat Genet. 1996 May;13(1):18-9 PMID: 8673096
  4. An integrated view of beta-cell dysfunction in type-II diabetes.
    Annu Rev Med. 1996;47:69-83 PMID: 8712804
  5. Glucose rapidly and reversibly decreases INS-1 cell insulin gene transcription via decrements in STF-1 and C1 activator transcription factor activity.
    Mol Endocrinol. 1998 Feb;12(2):207-19 PMID: 9482663
  6. Construction and selection of recombinant plasmids containing full-length complementary DNAs corresponding to rat insulins I and II.
    Proc Natl Acad Sci U S A. 1979 Oct;76(10):5036-40 PMID: 388427
  7. Insulin biosynthesis and diabetes mellitus.
    Clin Biochem. 1981 Oct;14(5):230-6 PMID: 7037227
  8. Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release.
    J Clin Invest. 1983 Jun;71(6):1544-53 PMID: 6134752
  9. Modulation of proinsulin messenger RNA after partial pancreatectomy in rats. Relationships to glucose homeostasis.
    J Clin Invest. 1985 Jun;75(6):2047-55 PMID: 3891788
  10. Structure and evolution of the insulin gene.
    Annu Rev Genet. 1985;19:463-84 PMID: 3909947
  11. Sequence-specific interactions of nuclear factors with the insulin gene enhancer.
    Cell. 1986 Apr 11;45(1):35-44 PMID: 3006925
  12. Substitution at codon 269 (glutamine --> proline) of the leptin receptor (OB-R) cDNA is the only mutation found in the Zucker fatty (fa/fa) rat.
    Biochem Biophys Res Commun. 1996 Jul 16;224(2):597-604 PMID: 8702432
  13. Molecular cloning of rat leptin receptor isoform complementary DNAs--identification of a missense mutation in Zucker fatty (fa/fa) rats.
    Biochem Biophys Res Commun. 1996 Aug 5;225(1):75-83 PMID: 8769097
  14. Technical aspects of quantitative competitive PCR.
    Biotechniques. 1996 Aug;21(2):268-72, 274-9 PMID: 8862812
  15. The human glucokinase gene beta-cell-type promoter: an essential role of insulin promoter factor 1/PDX-1 in its activation in HIT-T15 cells.
    Diabetes. 1996 Nov;45(11):1478-88 PMID: 8866550
  16. Distribution of glucagon receptors on hormone-specific endocrine cells of rat pancreatic islets.
    Endocrinology. 1996 Nov;137(11):5119-25 PMID: 8895386
  17. Effects of chronically elevated glucose levels on the functional properties of rat pancreatic beta-cells.
    Diabetes. 1996 Dec;45(12):1774-82 PMID: 8922365
  18. Transcriptional activation of the GLUT2 gene by the IPF-1/STF-1/IDX-1 homeobox factor.
    Mol Endocrinol. 1996 Nov;10(11):1327-34 PMID: 8923459
  19. Involvement of the homeodomain-containing transcription factor PDX-1 in islet amyloid polypeptide gene transcription.
    Biochem Biophys Res Commun. 1996 Dec 24;229(3):746-51 PMID: 8954967
  20. Disappearance of body fat in normal rats induced by adenovirus-mediated leptin gene therapy.
    Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14795-9 PMID: 8962134
  21. Prolonged exposure of human beta cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation.
    J Clin Invest. 1996 Dec 15;98(12):2805-12 PMID: 8981928
  22. The reduction of insulin gene transcription in HIT-T15 beta cells chronically exposed to high glucose concentration is associated with the loss of RIPE3b1 and STF-1 transcription factor expression.
    Mol Endocrinol. 1995 Sep;9(9):1127-34 PMID: 7491105
  23. Developmentally and hormonally regulated CCAAT/enhancer-binding protein isoforms influence beta-casein gene expression.
    Mol Endocrinol. 1995 Sep;9(9):1223-32 PMID: 7491114
  24. Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat.
    Diabetes. 1995 Dec;44(12):1447-57 PMID: 7589853
  25. NF-M (chicken C/EBP beta) induces eosinophilic differentiation and apoptosis in a hematopoietic progenitor cell line.
    EMBO J. 1995 Dec 15;14(24):6127-35 PMID: 8557032
  26. Chronic exposure of betaTC-6 cells to supraphysiologic concentrations of glucose decreases binding of the RIPE3b1 insulin gene transcription activator.
    J Clin Invest. 1996 Feb 15;97(4):1041-6 PMID: 8613527
  27. Defective fatty acid-mediated beta-cell compensation in Zucker diabetic fatty rats. Pathogenic implications for obesity-dependent diabetes.
    J Biol Chem. 1996 Mar 8;271(10):5633-7 PMID: 8621426
  28. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence.
    Nat Genet. 1997 Jan;15(1):106-10 PMID: 8988180
  29. Reduced insulin, GLUT2, and IDX-1 in beta-cells after partial pancreatectomy.
    Diabetes. 1997 Feb;46(2):258-64 PMID: 9000703
  30. Differentiation of glucose toxicity from beta cell exhaustion during the evolution of defective insulin gene expression in the pancreatic islet cell line, HIT-T15.
    J Clin Invest. 1997 Feb 1;99(3):534-9 PMID: 9022089
  31. Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM.
    Diabetes. 1997 Mar;46(3):408-13 PMID: 9032096
  32. Regulating adipogenesis.
    J Biol Chem. 1997 Feb 28;272(9):5367-70 PMID: 9102400
  33. Direct antidiabetic effect of leptin through triglyceride depletion of tissues.
    Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4637-41 PMID: 9114043
  34. Role of nitric oxide in obesity-induced beta cell disease.
    J Clin Invest. 1997 Jul 15;100(2):290-5 PMID: 9218505
  35. beta-cell function in normal rats made chronically hyperleptinemic by adenovirus-leptin gene therapy.
    Diabetes. 1997 Aug;46(8):1276-80 PMID: 9231651
  36. Leptin- or troglitazone-induced lipopenia protects islets from interleukin 1beta cytotoxicity.
    J Clin Invest. 1997 Oct 1;100(7):1750-4 PMID: 9312173
  37. Suppression of transcription factor PDX-1/IPF1/STF-1/IDX-1 causes no decrease in insulin mRNA in MIN6 cells.
    J Clin Invest. 1997 Oct 1;100(7):1840-6 PMID: 9312185
  38. Low density lipoprotein binding and uptake by human and rat islet beta cells.
    Endocrinology. 1997 Oct;138(10):4064-8 PMID: 9322913
  39. Leptin normalizes the impaired response of proinsulin mRNA to long chain fatty acids in heterozygous Zucker diabetic fatty rats.
    J Biol Chem. 1997 Oct 10;272(41):25648-51 PMID: 9325287
  40. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1.
    Nat Genet. 1997 Oct;17(2):138-9 PMID: 9326926
  41. Tissue triglycerides, insulin resistance, and insulin production: implications for hyperinsulinemia of obesity.
    Am J Physiol. 1997 Oct;273(4 Pt 1):E708-13 PMID: 9357799
  42. Pancreatic beta-cell-specific repression of insulin gene transcription by CCAAT/enhancer-binding protein beta. Inhibitory interactions with basic helix-loop-helix transcription factor E47.
    J Biol Chem. 1997 Nov 7;272(45):28349-59 PMID: 9353292
  43. Constitutive and impaired signaling of leptin receptors containing the Gln --> Pro extracellular domain fatty mutation.
    Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10657-62 PMID: 9380691
  44. Fatty acids decrease IDX-1 expression in rat pancreatic islets and reduce GLUT2, glucokinase, insulin, and somatostatin levels.
    J Biol Chem. 1997 Nov 28;272(48):30261-9 PMID: 9374511
  45. OB-Rb gene transfer to leptin-resistant islets reverses diabetogenic phenotype.
    Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):714-8 PMID: 9435258
  46. Reproducible high yield of rat islets by stationary in vitro digestion following pancreatic ductal or portal venous collagenase injection.
    Transplantation. 1987 May;43(5):725-30 PMID: 3033857
  47. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
    Anal Biochem. 1987 Apr;162(1):156-9 PMID: 2440339
  48. A mutational analysis of the insulin gene transcription control region: expression in beta cells is dependent on two related sequences within the enhancer.
    Proc Natl Acad Sci U S A. 1987 Dec;84(24):8819-23 PMID: 3321054
  49. Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy.
    J Clin Invest. 1988 May;81(5):1407-14 PMID: 3284912
  50. Evolution of abnormal insulin secretory responses during 48-h in vivo hyperglycemia.
    Diabetes. 1988 Feb;37(2):217-22 PMID: 3292316
  51. Transcriptional activation and repression by cellular DNA-binding protein C/EBP.
    J Virol. 1990 Apr;64(4):1517-22 PMID: 2157040
  52. Homologous desensitization of the insulinotropic glucagon-like peptide-I (7-37) receptor on insulinoma (HIT-T15) cells.
    Endocrinology. 1991 Jun;128(6):2880-8 PMID: 1645253
  53. Beta-cell dysfunction in hyperglycaemic rat models: recovery of glucose-induced insulin secretion with lowering of the ambient glucose level.
    Diabetologia. 1991 Sep;34(9):640-7 PMID: 1955096
  54. Differential expression of three C/EBP isoforms in multiple tissues during the acute phase response.
    J Biol Chem. 1992 Mar 15;267(8):5021-4 PMID: 1371993
  55. CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription.
    Genes Dev. 1992 Mar;6(3):439-53 PMID: 1547942
  56. Beta-cell dysfunction induced by chronic hyperglycemia. Current ideas on mechanism of impaired glucose-induced insulin secretion.
    Diabetes Care. 1992 Mar;15(3):442-55 PMID: 1559411
  57. Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the beta-cell function.
    J Clin Invest. 1992 Oct;90(4):1263-8 PMID: 1401063
  58. Chronic exposure of HIT cells to high glucose concentrations paradoxically decreases insulin gene transcription and alters binding of insulin gene regulatory protein.
    J Clin Invest. 1993 Jul;92(1):514-9 PMID: 8326016
  59. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle.
    J Clin Invest. 1994 Feb;93(2):870-6 PMID: 8113418
  60. IDX-1: a new homeodomain transcription factor expressed in rat pancreatic islets and duodenum that transactivates the somatostatin gene.
    EMBO J. 1994 Mar 1;13(5):1145-56 PMID: 7907546
  61. Differentiating glucose toxicity from glucose desensitization: a new message from the insulin gene.
    Diabetes. 1994 Sep;43(9):1085-9 PMID: 8070607
  62. Insulin-promoter-factor 1 is required for pancreas development in mice.
    Nature. 1994 Oct 13;371(6498):606-9 PMID: 7935793
  63. Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships.
    Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):10878-82 PMID: 7971976
  64. Pancreatic beta-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids.
    J Biol Chem. 1995 Jan 20;270(3):1295-9 PMID: 7836394
  65. Insulin expression in pancreatic islet cells relies on cooperative interactions between the helix loop helix factor E47 and the homeobox factor STF-1.
    Mol Endocrinol. 1994 Dec;8(12):1798-806 PMID: 7708065
  66. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications.
    Diabetes. 1995 Aug;44(8):863-70 PMID: 7621989
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
DOI
10.1172/JCI2401
Published
1998-06-01
Pages
2528-39
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC508842
Subset
IM
Grants
NIDDK NIH HHS · DK30457 · United States
NIDDK NIH HHS · DK30834 · United States
NIDDK NIH HHS · DK35449 · United States
External Links
PubMed source DOI: 10.1172/JCI2401 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2